Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Methylnaltrexone bromide
Relistor
Not routinely available
SMC (518/08)
29/03/2023
Indication
Opioid-induced constipation in advanced illness patients. See link to SMC advice for full details of restriction.
Therapeutic Area
Gastro-intestinal system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
12mg in 0.6ml solution for injection
Comments
-